Biosafety Level 3 Containment Services

We are dedicated to making significant advances in health safety, and our A/BSL-3 services exemplify this commitment. Combining broad-ranging expertise, rigorous safety protocols, small and large animal testing abilities, and state-of-the-art facilities, we strive to make substantial differences in global health outcomes. We have been performing infectious disease research for 80+ years for commercial, government, and academic clients and collaborators.

SR-Anatomic-Pathology-Hero-Image-1

Advancing Infectious Disease Research & Establishing Pandemic Preparedness

Your Trusted Partner for BSL-3 Select Agent Containment Research

Our BSL-3 facilities are designed to meet the highest standards of safety and containment, enabling the safe handling of potent and potentially lethal pathogens. Our comprehensive services encompass:

1. Advanced BSL-3 Laboratory Facilities:

  • Accredited BSL-3 laboratories equipped with all the equipment necessary to assure the highest level of biosafety.
  • The abilitity to conduct small to large animal (NHP) in vivo studies in BSL-3.
  • We can also conduct high-throughput screening, in vitro studies, and clinical and anatomic pathology capabilities in BSL-3.

2. Expert Scientific Team:

  • Experienced scientists with comprehensive knowledge of BSL-3 regulations and protocols, ensuring the safe and effective conduct of your research.
  • Expertise in a wide range of research disciplines, including virology, bacteriology, high throughput screen for BSL-3 agents, and infectious disease research, to cater to your specific needs.
  • Collaborative and communicative team dedicated to providing ongoing support and guidance throughout your research project.

3. Customized Research Solutions:

  • Tailored research services designed to meet your specific project objectives, from feasibility studies to full-scale research projects.
  • Access to cutting-edge technologies and methodologies to facilitate groundbreaking research on high-containment pathogens.
  • Flexible project management and clear communication to ensure seamless collaboration and timely completion of your research.

4. Regulatory Support and Compliance:

  • Expert guidance on navigating regulatory requirements for BSL-3 research, including biosafety protocols and documentation.
  • Assistance with regulatory submissions and ongoing communication with regulatory authorities to ensure compliance.

5. Unwavering Commitment to Safety and Ethics:

We firmly believe that responsible biosafety practices are paramount to ensuring the safety of our researchers, the environment, and the public. Our commitment to ethical research translates into:

  • Rigorous adherence to the highest biosafety standards and regulations.
  • Continuous investment in advanced safety technologies and training programs.
  • Open communication and transparency throughout the research process.

BSL-3 Expertise: Partner With Us

Let us be your trusted partner in navigating the complex and demanding field of BSL-3 research. Our commitment to safety, expertise, and collaboration will empower you to conduct your research with confidence and contribute to groundbreaking discoveries that improve human health and well-being.

Contact us today to discuss your specific BSL-3 research needs and embark on a journey towards impactful discoveries in a secure and controlled environment.

Southern Research News

Southern Research awards biotech funds, bringing new jobs and business to Alabama

June 28, 2024

June 27, 2024, Birmingham, Ala – Southern Research has awarded more than $2.7 million in funds to eight biotech companies through a fund established as a result of the Innovate Alabama Tax Credit.
Read More

Southern Research Selects Chief Operating Officer

May 9, 2024

May 8, 2024 Birmingham, Ala. – Harry C. Ledebur, Jr., Ph.D., is joining Southern Research as Chief Operating Officer, bringing to the role more than 25 years of experience across the pharmaceutical, biotechnology, and contract-research industry. In his new position at Southern ...
Read More

Southern Research Awarded Grant to Develop Novel Antidotes for Arsenical Poisoning

April 11, 2024

Project Aims to Deliver Safer and More Effective Treatments for Cutaneous Injuries Southern Research is pleased to announce the award of a UG3/UH3 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (N...
Read More